Autres langues DIAGNOS Inc.

Actions

ADK

CA2524423068

Temps Différé Toronto S.E. Autres places de cotation 20:51:21 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,32 ^CAD	+6,67 %		+16,07 %	-19,75 %

16/04	DIAGNOS inc. accélère sa demande d'homologation d'instrument médical auprès de Santé Canada et de la FDA des États-Unis pour ses 4 nouveaux modules d'analyse et planifie la certification ISO 27001	CI
02/04	DIAGNOS Inc. nomme Philippe Couillard à son conseil d?administration	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification	16/04
DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification	16/04
DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th	09/04
DIAGNOS Announces Grant of Stock Options	03/04
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors	02/04
DIAGNOS Inc. Appoints Philippe Couillard to Its Board of Directors	02/04
Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units	22/03
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement	22/03
DIAGNOS Inc. announced that it has received CAD 0.578 million in funding	22/03
Diagnos Announces Grant Of Stock Options	04/03
DIAGNOS Announces Grant of Stock Options	04/03
DIAGNOS Inc. Appoints Michael Braeuel to Board of Directors	29/02
DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors	29/02
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28/02
DIAGNOS Announces Closing Of First Tranche Of Private Placement	27/02
DIAGNOS Announces Closing of First Tranche of Private Placement	27/02
DIAGNOS Inc. announced that it expects to receive CAD 1.19244 million in funding	27/02
Diagnos Announces Variation in One Insider Ownership of Common Shares	23/02
DIAGNOS recognized as a Top TSX Venture Exchange Company	21/02
DIAGNOS Appoints New Chief Operating Officer	16/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues DIAGNOS Inc.

Actions

ADK

CA2524423068

Autres langues

Filtres